載脂蛋白C3(APOC3)重組蛋白
Recombinant Apolipoprotein C3 (APOC3)
Apo-C3; APOCIII; APOC-III
- 編號RPB890Hu03
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量12.5kDa
- 實際分子量16kDa(差異分析請參閱說明書)
- 片段與標簽Ser21~Ala99 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點5.8
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 871¥ 2178¥ 4356¥ 13068¥ 32670
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure . Gene Sequencing (extract)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APB890Hu01 | 載脂蛋白C3(APOC3)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPB890Hu03 | 載脂蛋白C3(APOC3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB890Hu02 | 載脂蛋白C3(APOC3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB890Hu01 | 載脂蛋白C3(APOC3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB890Hu01 | 載脂蛋白C3(APOC3)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB890Hu22 | 載脂蛋白C3(APOC3)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB890Hu | 載脂蛋白C3(APOC3)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB890Hu | 載脂蛋白C3(APOC3)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Atherosclerosis | Up-reCavia (Guinea pig )lation of Hnf1α gene expression in the liver of rats with experimentally induced chronic renal failure – A possible link between circulating PCSK9 and triacylglycerol concentrations [Pubmed:26978583] |
| The Journal of Lipid Research | Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism[Pubmed:27040449] |
| Journal of Chromatography A | Application of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis[S0021967317311858] |
| J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans[33407555] |